Five-year renal function outcomes after sabr for primary renal cell carcinoma: a report from the international radiosurgery oncology consortium of the kidney (irock)
International journal of radiation oncology, biology, physics（2023）
摘要
There was no observed difference between renal function outcomes in patients with a solitary vs. bilateral kidneys. While larger tumor size may increase the risk of eGFR decline post-SABR, treatment of a solitary kidney does not appear to increase the risk of renal dysfunction long-term.
更多查看译文
关键词
renal cell carcinoma,primary renal cell carcinoma,sabr,international radiosurgery oncology consortium
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要